759 related articles for article (PubMed ID: 25487025)
1. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.
Duncan EJ; Cheetham ME; Chapple JP; van der Spuy J
Subcell Biochem; 2015; 78():243-73. PubMed ID: 25487025
[TBL] [Abstract][Full Text] [Related]
2. HSP70-HSP90 Chaperone Networking in Protein-Misfolding Disease.
Prodromou C; Aran-Guiu X; Oberoi J; Perna L; Chapple JP; van der Spuy J
Subcell Biochem; 2023; 101():389-425. PubMed ID: 36520314
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule modulation of cellular chaperones to treat protein misfolding disorders.
Sloan LA; Fillmore MC; Churcher I
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):666-81. PubMed ID: 19736625
[TBL] [Abstract][Full Text] [Related]
4. The role of molecular chaperones in human misfolding diseases.
Broadley SA; Hartl FU
FEBS Lett; 2009 Aug; 583(16):2647-53. PubMed ID: 19393652
[TBL] [Abstract][Full Text] [Related]
5. In vivo aspects of protein folding and quality control.
Balchin D; Hayer-Hartl M; Hartl FU
Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
[TBL] [Abstract][Full Text] [Related]
6. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
Chaari A; Hoarau-Véchot J; Ladjimi M
Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
[TBL] [Abstract][Full Text] [Related]
7. Targeting Hsp70 facilitated protein quality control for treatment of polyglutamine diseases.
Davis AK; Pratt WB; Lieberman AP; Osawa Y
Cell Mol Life Sci; 2020 Mar; 77(6):977-996. PubMed ID: 31552448
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly.
Hervás R; Oroz J
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276458
[TBL] [Abstract][Full Text] [Related]
9. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
10. Protein folding, misfolding and quality control: the role of molecular chaperones.
Papsdorf K; Richter K
Essays Biochem; 2014; 56():53-68. PubMed ID: 25131586
[TBL] [Abstract][Full Text] [Related]
11. Chaperoning proteins for destruction: diverse roles of Hsp70 chaperones and their co-chaperones in targeting misfolded proteins to the proteasome.
Shiber A; Ravid T
Biomolecules; 2014 Jul; 4(3):704-24. PubMed ID: 25036888
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and Functions of Spatial Protein Quality Control.
Sontag EM; Samant RS; Frydman J
Annu Rev Biochem; 2017 Jun; 86():97-122. PubMed ID: 28489421
[TBL] [Abstract][Full Text] [Related]
13. The role of the cytosolic HSP70 chaperone system in diseases caused by misfolding and aberrant trafficking of ion channels.
Young JC
Dis Model Mech; 2014 Mar; 7(3):319-29. PubMed ID: 24609033
[TBL] [Abstract][Full Text] [Related]
14. Inducible HSP70 is critical in preventing the aggregation and enhancing the processing of PMP22.
Chittoor-Vinod VG; Lee S; Judge SM; Notterpek L
ASN Neuro; 2015; 7(1):. PubMed ID: 25694550
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy.
Abu-Baker A; Messaed C; Laganiere J; Gaspar C; Brais B; Rouleau GA
Hum Mol Genet; 2003 Oct; 12(20):2609-23. PubMed ID: 12944420
[TBL] [Abstract][Full Text] [Related]
16. The family of mammalian small heat shock proteins (HSPBs): implications in protein deposit diseases and motor neuropathies.
Boncoraglio A; Minoia M; Carra S
Int J Biochem Cell Biol; 2012 Oct; 44(10):1657-69. PubMed ID: 22484489
[TBL] [Abstract][Full Text] [Related]
17. The Nucleolus as a Proteostasis Regulator.
Amer-Sarsour F; Ashkenazi A
Trends Cell Biol; 2019 Nov; 29(11):849-851. PubMed ID: 31473054
[TBL] [Abstract][Full Text] [Related]
18. The Role of Small Heat Shock Proteins in Protein Misfolding Associated Motoneuron Diseases.
Tedesco B; Ferrari V; Cozzi M; Chierichetti M; Casarotto E; Pramaggiore P; Mina F; Galbiati M; Rusmini P; Crippa V; Cristofani R; Poletti A
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233058
[TBL] [Abstract][Full Text] [Related]
19. Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity.
Brehme M; Voisine C
Dis Model Mech; 2016 Aug; 9(8):823-38. PubMed ID: 27491084
[TBL] [Abstract][Full Text] [Related]
20. The chaperone proteins HSP70, HSP40/DnaJ and GRP78/BiP suppress misfolding and formation of β-sheet-containing aggregates by human amylin: a potential role for defective chaperone biology in Type 2 diabetes.
Chien V; Aitken JF; Zhang S; Buchanan CM; Hickey A; Brittain T; Cooper GJ; Loomes KM
Biochem J; 2010 Nov; 432(1):113-21. PubMed ID: 20735358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
